Get the Stockscreener App
3.48
2.25%
-0.08
Psyence Biomedical Ltd stock is traded at $3.48, with a volume of 18,627.
It is down -2.25% in the last 24 hours and up +21.25% over the past month.
Psyence Biomedical Ltd is a life science biotechnology company pioneering the use of natural psychedelics in mental health and wellbeing. It develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The company has commenced the clinical trial process to evaluate the safety and efficacy of its product candidates. It cultivates natural psilocybin mushrooms at its federally licensed facility in Southern Africa. This product is produced for export to its partners across the world to be processed into a standardized encapsulated product.
See More
Previous Close:
$3.56
Open:
$3.51
24h Volume:
18,627
Relative Volume:
0.25
Market Cap:
$13.27M
Revenue:
-
Net Income/Loss:
$1.52M
P/E Ratio:
-0.5505
EPS:
-6.3213
Net Cash Flow:
$-1.14M
1W Performance:
+0.29%
1M Performance:
+21.25%
6M Performance:
+12.62%
1Y Performance:
-83.38%
1-Day Range:
$3.43
$3.57
1-Week Range:
$3.22
$3.58
52-Week Range:
$0.6254
$34.62
Psyence Biomedical Ltd Stock (PBM) Company Profile
Compare PBM vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBM
Psyence Biomedical Ltd
|
3.48 | 12.78M | 0 | 1.52M | -1.14M | -6.3213 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Psyence Biomedical Ltd Stock (PBM) Latest News
Psyence Biomedical (PBM) Slips 2.27% as Shares Test Key $3.40 LevelFactor Valuation - dars.gov.et
Psyence Biomedical Ltd (PBM) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Psyence Biomedical Ltd. Revenue Breakdown – NASDAQ:PBMWW - TradingView
PBM News | PSYENCE BIOMEDICAL LTD (NASDAQ:PBM) - ChartMill
Psyence Biomedical Details NPX-5 Trial Progress and Integrated Psychedelic Platform in August Investor Update - TipRanks
Psyence BioMed (Nasdaq: PBM) outlines psilocybin and ibogaine clinical plans - Stock Titan
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBM - TradingView
Psyence Biomedical Ltd (PBM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Warrants (PBMWW) Surge 48%: A Closer Look at the Speculative MovePCR Spike - dars.gov.et
Psyence Biomedical Ltd (PBM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
PBM|Psyence Biomedical Ltd|Price:2.950|Chg%:+0.130 - TradingKey
Psyence Biomedical Ltd (PBM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBM|Psyence Biomedical Ltd|Price:3.580|Chg%:+0.230 - tradingkey.com
Psyence Biomedical Ltd (PBM) Cash Flow - TradingKey
Psyence Biomedical Ltd (PBM) Balance Sheet - TradingKey
Psyence Biomedical Ltd (PBM) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBM) Dividends & Stock Splits: Historical Payouts and Event Timeline - tradingkey.com
PBM|Psyence Biomedical Ltd|Price:3.030|Chg%:+0.080 - TradingKey
Psyence Biomedical Ltd (PBM) Income Statement - TradingKey
Psyence Biomedical Company Profile & Introduction - Moomoo
Enterprise value to EBIT forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to earnings forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to book forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Enterprise value to revenue forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Price to sales forward of Psyence Biomedical Ltd. – NASDAQ:PBMWW - TradingView
Psyence Biomedical Warrant (PBMWW) Surges 22% – Can Low-Priced Momentum Continue?Negative Gamma - dars.gov.et
Psyence Biomedical Ltd. (PBM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
PBMPsyence Biomedical Ltd Earnings - Finviz
Psyence Biomedical Ltd. (PBM) Retreats Amid Sector Caution: Support Levels Under ScrutinyIceberg Order - dars.gov.et
Tranche Update on Psyence Biomedical Ltd.'s Equity Buyback Plan announced on January 12, 2026. - marketscreener.com
PBM Stock On Track For Best Session On Report Of Upcoming Trump Executive Order On Psychedelic Ibogaine - Stocktwits
$Psyence Biomedical (PBM.US)$ - Moomoo
Psyence Biomedical (PBM) Drops Over 6% as Shares Test Key Support LevelsSocial Sentiment - po-news-eg.net
Psyence Biomedical (Nasdaq: PBM) outlines losses, cash runway and trial risks in 20-F - Stock Titan
Psyence Biomedical Ltd. Reports Earnings Results for the Full Year Ended March 31, 2026 - marketscreener.com
Nasdaq, S&P 500 Futures Fall, Oil Risk Back In Focus After Trump’s Iran Escalation: Why PBM, FRMI, ASTS, BATL Are Keeping Traders Engaged Today - Stocktwits
PBMWW | Psyence Biomedical Ltd. Warrant Insider Trading - Quiver Quantitative
Psyence Biomedical Ltd (PBMWW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Psyence Biomedical Ltd (PBMWW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Psyence Biomedical Ltd (PBMWW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Psyence Biomedical Ltd (PBMWW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Psyence Biomedical Ltd (PBMWW) Valuation: PE, PB & Fair Value Analysis - TradingKey
Psyence Biomedical Ltd (PBMWW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Psyence Biomedical Ltd (PBMWW) Institutional Confidence - TradingKey
Psyence Biomedical Ltd (PBMWW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Psyence Biomedical Ltd (PBMWW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
PBMWW Warrants Slide 9.25% as Psyence Biomedical Faces Continued Selling PressureGamma Exposure - newsline.com
Psyence Biomedical Ltd Stock (PBM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.52%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):